Trade Summary

1 week ago, RA CAPITAL MANAGEMENT, L.P., serving as 10% owner Owner at Werewolf Therapeutics, Inc. (HOWL), sold 678,226 shares at $0.37 per share, for a total transaction value of $253,568.65. Following this transaction, RA CAPITAL MANAGEMENT, L.P. now holds 361,229 shares of HOWL.

This sale represents a 65.25% decrease in RA CAPITAL MANAGEMENT, L.P.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, June 9, 2026 and publicly disclosed via SEC Form 4 filing on Friday, June 12, 2026 (accepted Jun 11, 8:13 PM ET), 3 days after the trade was made.

Werewolf Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.